tiprankstipranks
Trending News
More News >
Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD
US Market

Galmed Pharmaceuticals (GLMD) Income Statement

Compare
1,306 Followers

Galmed Pharmaceuticals Income Statement

Last quarter (Q2 2025), Galmed Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Galmed Pharmaceuticals's net income was $-2.50M. See Galmed Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -83.00K$ -31.00K$ -35.00K$ -42.00K$ -39.00K
Operating Expenses
$ 6.20M$ -7.49M$ 17.65M$ 32.88M$ 30.21M
Depreciation and Amortization
$ 83.00K$ 31.00K$ 35.00K$ 42.00K$ 39.00K
EBITDA
$ -7.42M$ -6.87M$ -17.62M$ -32.84M$ -30.17M
Operating Income
$ -6.28M$ 7.49M$ -17.65M$ -32.88M$ -30.21M
Other Income/Expenses
$ -1.24M$ -14.40M$ -215.00K$ 414.00K$ 1.44M
Pretax Income
$ -7.52M$ -6.91M$ -17.87M$ -32.47M$ -28.77M
Net Income
$ -7.52M$ -6.91M$ -18.57M$ -31.95M$ -27.61M
Per Share Metrics
Basic EPS
$ -8.08$ -30.05$ -11.08$ -19.48$ -19.46
Diluted EPS
$ -8.08$ -29.95$ -11.08$ -19.48$ -19.46
Weighted Average Shares Outstanding
930.82K 230.00K 1.68M 1.64M 1.42M
Weighted Average Shares Outstanding (Diluted)
930.82K 230.79K 1.68M 1.64M 1.42M
Currency in USD

Galmed Pharmaceuticals Earnings and Revenue History